搜索结果101-110 的 889 / anti-TNF drugs
Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
... treatment or patients that are experiencing an upper digestive disease in order to standardize and validate outcome measures. Data will be used to establish ...
Prior to an operation, UC is treated with antibiotic therapy, immunomodulatory therapy and immunosuppressive agents. While there is an increasing number of ...
The purpose of this study is to evaluate a new treatment using a potent Poly polymerase (PARP) inhibitor known as Niraparib. Niraparib will be combined with ...
120 研究神经科(仅限仍在招募的研究). 按院区、状态和其他条件筛选该研究列表。 Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients ...
The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma ... drugs in the iPSC-derived muscle cells ...
... treatment-related adverse events reported by National Cancer Institute (NCI) ... Therapy in People With a Brain Tumor Called Glioblastoma. Rochester ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。